• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

H1N1 Vaccination Safe in Children With Rheumatologic Conditions: Presented at ACR/ARHP

tetano

Editor, Senior Moderator
ATLANTA -- November 9, 2010 -- Children with rheumatologic conditions should receive H1N1 vaccination, according to results of a study presented here at the 2010 Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP).

"The benefits of vaccination with H1N1 monovalent inactivated vaccine outweighed the risk in this group of patients with chronic inflammatory rheumatic diseases," stated Catherine F. Cortot, MD, Children's Hospital, Boston, Massachusetts, speaking here at a poster presentation on November 8. "Children with chronic rheumatic inflammatory disease are more susceptible to infections," she added. These children were a target group for immunisation with H1N1 influenza vaccine; however, the safety and efficacy of the vaccine in such patients was not previously known.

This prospective study assessed the toxicity profile and effectiveness during actual use of the H1N1 vaccine in children with chronic inflammatory rheumatic diseases from the rheumatology clinic of a large, tertiary-care children's hospital. Eligible patients (n = 120) had received at least 1 dose of the influenza A (H1N1) 2009 monovalent, unadjuvanted, inactivated vaccine.

...

http://www.docguide.com/news/content.nsf/news/852576140048867C852577D6006A2348
 
Back
Top Bottom